Q2 2023 EPS Estimates for GoHealth, Inc. (NASDAQ:GOCO) Reduced by William Blair

GoHealth, Inc. (NASDAQ:GOCO – Get Rating) – Investment analysts at William Blair lowered their Q2 2023 earnings estimates for shares of GoHealth in a research note issued on Monday, May 8th. William Blair analyst A. Klauber now forecasts that the company will earn ($2.66) per share for the quarter, down from their previous estimate of ($2.27). The consensus estimate for GoHealth’s current full-year earnings is ($5.19) per share. William Blair also issued estimates for GoHealth’s Q2 2023 earnings at ($2.66) EPS, Q3 2023 earnings at ($3.08) EPS, Q3 2023 earnings at ($3.08) EPS, Q4 2023 earnings at $1.99 EPS, FY2023 earnings at ($4.77) EPS, FY2023 earnings at ($4.77) EPS, FY2024 earnings at ($4.19) EPS and FY2024 earnings at ($4.19) EPS.

Other equities research analysts have also recently issued reports about the stock. Royal Bank of Canada cut their price objective on shares of GoHealth from $15.00 to $14.00 and set a “sector perform” rating for the company in a research report on Friday, March 17th. Credit Suisse Group lifted their price target on shares of GoHealth from $7.00 to $8.50 and gave the company an “underperform” rating in a research report on Tuesday, April 4th. Finally, Bank of America raised their price objective on shares of GoHealth from $9.75 to $11.00 in a research note on Friday, March 17th.

GoHealth Stock Performance

GOCO opened at $14.64 on Thursday. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 1.40. The company has a market cap of $322.59 million, a price-to-earnings ratio of -0.87 and a beta of 2.12. GoHealth has a 52-week low of $4.93 and a 52-week high of $19.85. The firm’s fifty day simple moving average is $13.84 and its two-hundred day simple moving average is $12.02.

GoHealth (NASDAQ:GOCO – Get Rating) last issued its quarterly earnings results on Monday, May 8th. The company reported ($1.12) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.74) by $0.62. The business had revenue of $183.16 million for the quarter, compared to analyst estimates of $180.97 million. GoHealth had a negative net margin of 23.54% and a negative return on equity of 17.36%. During the same quarter in the prior year, the business posted ($1.80) EPS.

Institutional Investors Weigh In On GoHealth

Hedge funds have recently modified their holdings of the stock. FMR LLC boosted its holdings in GoHealth by 378.6% in the second quarter. FMR LLC now owns 63,612 shares of the company’s stock worth $38,000 after purchasing an additional 50,322 shares during the period. Point72 Hong Kong Ltd raised its stake in shares of GoHealth by 302.5% during the first quarter. Point72 Hong Kong Ltd now owns 31,980 shares of the company’s stock valued at $38,000 after purchasing an additional 24,034 shares in the last quarter. Virtus Family Office LLC bought a new stake in GoHealth in the third quarter worth about $38,000. Price T Rowe Associates Inc. MD raised its position in GoHealth by 461.9% in the second quarter. Price T Rowe Associates Inc. MD now owns 65,300 shares of the company’s stock worth $39,000 after acquiring an additional 53,679 shares in the last quarter. Finally, Virtu Financial LLC acquired a new stake in GoHealth during the 4th quarter worth about $107,000.

GoHealth Company Profile

(Get Rating)

GoHealth, Inc operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.